beta-3 Adrenergic R/ADRB3 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NB100-93369
Key Product Details
Species Reactivity
Human
Applications
Peptide ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Peptide with sequence PHENSSLAPWPD-C corresponding to N-Terminus according to NP_000016.1.
Epitope
PHENSSLAPWPD-C
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for beta-3 Adrenergic R/ADRB3 Antibody
Western Blot: beta-3 Adrenergic R/ADRB3 Antibody [NB100-93369]
Western Blot: beta-3 Adrenergic R/ADRB3 Antibody [NB100-93369] - (0.03ug/ml) staining of Human Brain (Cerebellum) 35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.Applications for beta-3 Adrenergic R/ADRB3 Antibody
Application
Recommended Usage
Peptide ELISA
Detection limit 1:128000
Western Blot
0.03 - 0.1 ug/ml
Application Notes
WB: Approx. 45 kDa band observed in human brain (cerebellum, cerebral cortex, frontal cortex) lysates (calculated MW of 43.5 kDa band according to NP_000016.1).
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: beta-3 Adrenergic R/ADRB3
Long Name
Beta-3 Adrenergic Receptor
Alternate Names
ADRB3, ADRB3R, B3AR, beta-3 AdrenergicR, beta3 AdrenergicR
Entrez Gene IDs
155 (Human)
Gene Symbol
ADRB3
UniProt
Additional beta-3 Adrenergic R/ADRB3 Products
Product Documents for beta-3 Adrenergic R/ADRB3 Antibody
Product Specific Notices for beta-3 Adrenergic R/ADRB3 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...